Archive

Idiopathic Chodoidal Neovascular Membrane in a 12-year-old Girl Journal > /en/journal/2018/6/6
Choroidal neovascularization (CNV) is a rare but serious cause of visual impairment in children.The case report of a girl with a unilateral classical choroidal neovascular membrane has been presented. The differential diagnosis of possible etiology and the clinical course of this sight threatening condition during treatment have been documented. The similar cases in pediatric patients in foreign l...
Uveal Melanoma In A 15-Year-Old Girl. Case Report Journal > /en/journal/2021/2/6
Uveal melanoma is the most common intraocular tumour in adults, it is a form of cancer that affects mostly older adults, as the average age at detection of this tumour is 60 years, but it can occur in any age group with no significant gender difference. However, uveal melanoma is very rare in children compared to the adult population, accounting for 1 % of all cases. In pediatric patients, maligna...
Effect of Ranibizumab and Aflibercept on Retinal Pigment Epithelial Detachment, Subretinal, and Intra-Retinal Fluid in Age-Related Macular Degeneration Journal > /en/journal/2022/4/3
Purpose: The aim of the study was to compare the effect of three initial doses of the anti-VEGF ranibizumab and aflibercept medication on serous pigment epithelial detachment (PED), subretinal fluid (SRF) and intraretinal fluid (IRF) in the macula of treatment naive neovascular AMD (nvAMD) patients. Material and Methods: The cohort consists of 148 patients, of which 74 patients were treated with r...
Diabetic Macular Edema – Diagnostics and Treatment Guidelines Journal > /en/journal/2023/5/2
Together with diabetic retinopathy, diabetic macular edema (DME) ranks among the most common causes of severe loss of vision in working adults. Due to recent developments in imaging methods, new classification schemes of DME have been created. In addition to this, new treatment options have been introduced (new intravitreal drugs as well as treatment protocols). At the same time laser, surgical as...
Diabetic Retinopathy – Diagnostics and Treatment Guidelines Journal > /en/journal/2023/5/3
Diabetic retinopathy is one of the most common complications of diabetes mellitus and represents a serious health, social and economic problem. With the expected increase in the number of patients with diabetes, it is becoming the leading cause of severe vision loss in the working-age population. The presented guidelines summarize the current knowledge about this disease in order to standardize an...
Diabetic Retinopathy and Diabetic Macular Edema – Screening Journal > /en/journal/2023/5/4
Diabetic retinopathy (DR) and diabetic macular edema (DME) are leading causes of severe visual loss in the working population. Therefore, both DR and DME have a significant socioeconomic and health impact, which taking into account the epidemiologic predictions is expected to increase. A crucial role in the management of DR and DME (not only for individuals, but also for the population) is played ...
Pars Plana Vitrectomy in the Treatment of Rhegmatogenous Retinal Detachment Journal > /en/journal/2024/1/2
Aim: The aim of the study is to retrospectively evaluate the anatomical success rate and functional results of 25G+ PPV in the treatment of newly diagnosed rhegmatogenous retinal detachment (RRD). Material and Methods: The set consists of 152 eyes of 152 patients, of which 71 (47%) were men, average age 54 years, operated on by one surgeon for RRD at the Eye Clinic of the University Hospital and M...
Surgical Treatment of Rhegmatogenous Retinal Detachment in the Only Seeing Eye Journal > /en/journal/2025/1/4
Aim: To retrospectively evaluate the anatomical and functional success of surgical treatment of rhegmatogenous retinal detachment (RRD) in the only remaining seeing eye. Material and methods: The study included 28 eyes of 28 patients, 19 (68%) of whom were men, with an average age of 46 years. They were operated on by a single surgeon for RRD at the Eye Clinic of the University Hospital and Facult...
Retinal Vein Occlusion Guidelines Journal > /en/journal/2024/6/2
Retinal vein occlusion and its complications are among the most common causes of severe loss of sight in developed countries. In recent years, developments in imaging methods have been introduced, leading to an improvement in diagnostic possibilities. At the same time new treatment options have become available (new intravitreal drugs and treatment protocols, laser and surgical methods). The prese...
Rhegmatogenous Retinal Detachment in Childhood Journal > /en/journal/2025/5/2
Aims: To retrospectively evaluate the anatomical and functional success of surgical treatment for rhegmatogenous retinal detachment (RRD) in pediatric patients aged 18 years and younger. Material and methods: The study includes 14 eyes of 14 patients, 9 (64%) of whom were males, with an average age of 12 years. All patients underwent surgery for rhegmatogenous retinal detachment (RRD) performed by...
The Use of Anti-VEGF Preparations and PDT in the Treatment of Retinal Juxtapapillary Hemangioma – A Case Report Journal > /en/journal/2014/5/5
Aim: The aim of this paper is to present clinical experience with the therapy of retinal juxtapapillary hemangioma using the intravitreal application of anti-VEGF substance (bevacizumab) and photodynamic therapy (PDT) with verteporfine (Visudyne). Material and methods: The authors present a case of a 34 years old male patient with diagnosed retinal hemangioma localized on the optic disc. Subjectiv...
Contraception and Ocular Thromboembolic Episodes Journal > /en/journal/2013/2/7
The aim of the paper is to warn of the retinal vein occlusion possibility due to the using of hormonal contraceptive pills in young female patients. A case report of 22 years old female patient hospitalized at the Department of Ophthalmology, School of Medicine, Masaryk University, Brno, Czech Republic, E.U., with sudden decrease of the left eye visual acuity is presented. After excluding other ca...
Photodynamic Therapy with Verteporfin in Treatment of Wet Form ARMD – Long Term Results Journal > /en/journal/2012/3/1
Photodynamic therapy with Verteporfin (Visudyne - Novartis AG, Basel, Switzerland) is a method designed for treatment of the wet form of age-related macular degeneration. Effectiveness of photodynamic therapy with Verteporfin we approved on our department in group of 301 patients (114 males, 187 women) of average age 73.5 years with predominantly classic choroidal neovascular membrane in subfoveal...
Photodynamic Therapy with Verteporfin in Treatment of Myopic Neovascular Choroideal Membranes Journal > /en/journal/2012/4/1
The aim of this study was to evaluate efficiency and long-term stabilization effect in patients with classic type of myopic choroidal neovascular membrane (CNV), treated with photodynamic therapy (PDT) with verteporfin (Visudyne – Novartis AG, Basel, Switzerland). We have verified the efficiency of photodynamic therapy with verteporfin in group of 51 eyes (17 men, 34 women), mean age 49,5 years wi...
Ranibizumab in the ARMD Wet Form Treatment – Two Years Results Obtained from the AMADEuS Registry Journal > /en/journal/2012/5/1
Aim: The aim of this study was the retrospective follow up of Age-Related Macular Degeneration (ARMD) wet form patients treated with ranibizumab during 24 months period. The data were recorded into the AMADEuS (Age-related MAcular DEgeneration in patientS in the Czech Republic) Registry and after their evaluation compared with treatment results obtained from other departments of ophthalmology coll...